Skip to main content
market.news — Markets without borders

Markets news from 180+ trusted publishers·13 countries·Every story cited·Free

🇺🇸United States markets · 301 articles · Daily briefing at 6am ET
Change region: top-right pill · or pick from list at the bottom
Live

United States — Top Stories

More →
📈 United States Stock Lookup· Live data via Finnhub
📈

Search for any stock, ETF or crypto

Enter a company name or ticker symbol above

S&P 500 Sector Breakdown

More →

Semiconductors

+0.47%

Financials

-0.14%

Consumer Staples

-0.37%

Banking

+0.31%

Healthcare

-0.74%

Energy

+0.69%

Pharmaceuticals

-1.10%

Consumer Cyclical

+15.32%

Auto

+0.76%

Media

-2.00%

United States Markets

More →
🇺🇸 United States

Novo Nordisk Trial Failure Drags Monte Rosa and BioAge Shares Into Sharp Decline

Novo Nordisk's failed heart drug trial triggered a selloff in Monte Rosa (GLUE) and BioAge Labs (BIOA)

Aug 1, 2026

🇺🇸 United States

Space-Eyes Plans US IPO Through Merger with McKinley Acquisition: Counter-Drone Specialist Eyes Public Markets

Space-Eyes (ticker: CUAS) is planning a US IPO through a merger with McKinley Acquisition Corp, seeking public market capital to scale its counter-drone technology platform

Aug 1, 2026

🇺🇸 United States

Alimentation Couche-Tard Acquires Zabka Group in Poland, Expanding European Convenience Retail Footprint

Alimentation Couche-Tard (ANCTF) is acquiring Poland's Zabka Group, expanding its European convenience retail footprint into one of Central Europe's highest-growth markets

Aug 1, 2026

🇺🇸 United States

Q2 Earnings Beats Across Sectors: AbbVie EPS $3.65 vs $2.19 est, Chevron $6.11 vs $4.24 est, nVent $1.45 vs $0.93 est

AbbVie Q2 EPS of $3.65 beat the $2.19 estimate by 67%, driven by Skyrizi and Rinvoq immunology franchise strength; GF Score 76/100

Aug 1, 2026

🇺🇸 United States

Opioid Addiction Specialist Stock Sets Up as Profits Surge 108%: IBD Flags Technical Entry Signal

An opioid addiction treatment pharma specialist reported profit growth of 108%, reflecting accelerating prescription volume and improving payer coverage for addiction medicine

Aug 1, 2026

🇺🇸 United States

Garmin Stock Surges on Fitness Segment Strength: What Investors Are Missing in the Valuation

Garmin (GRMN) surged this week as its fitness segment demonstrated strong growth, with the company's smartwatch and cycling computer lines gaining meaningful market share

Aug 1, 2026

🇺🇸 United States

Amazon Shares Surge 13% as AWS Posts Fastest Cloud Growth in Four Years, Easing AI Spending Fears

Amazon shares surged 13% as AWS reported its fastest revenue growth rate in four years, validating the company's heavy AI infrastructure investment thesis

Aug 1, 2026

🇺🇸 United States

AbbVie Q2 Beats with $16.99B Revenue and $3.65 EPS but Cuts Guidance on $10.9 Billion Apogee Acquisition

AbbVie Q2 revenue hit $16.99 billion and adjusted EPS reached $3.65, both above Wall Street estimates on strength in Skyrizi and Rinvoq immunology sales

Aug 1, 2026

🇺🇸 United States

Elon Musk Rejects Tesla China Split Reports as SpaceX-Tesla Merger Speculation Intensifies

Elon Musk denied reports of a Tesla China business split, which had suggested a partial separation of Tesla's Chinese operations from its US parent entity

Aug 1, 2026

🇺🇸 United States

Analysts Warm to Amazon After AWS Surge: Street Consensus Shifts Bullish on Cloud Growth Outlook

Analyst community is warming to Amazon's growth story as AWS cloud revenue reaccelerates, with multiple sell-side firms raising price targets following Q2 results

Aug 1, 2026

🇺🇸 United States

Colgate-Palmolive Undervalued After Q2 Miss While Portland General Electric Faces Overvaluation Question

Colgate-Palmolive (CL) missed Q2 earnings estimates but GF Score of 85/100 suggests the stock remains fundamentally attractive at current levels after the earnings-driven pullback

Aug 1, 2026

🇺🇸 United States

Q2-Q3 Earnings Roundup: Moog Raises Guidance, WisdomTree Beats, RBC Bearings Strong—While TXNM and Moderna Miss Estimates

Moog Inc (MOG.A) Q3 EPS beat at $4.74, raised full-year guidance, with GF Score 78/100; WisdomTree Q2 EPS $0.28 beat with GF Score 87/100

Aug 1, 2026

🌍 Browse by region13 country markets

📬 Get the Daily Briefing — Free

Daily — 6am ET · United States pre-market analysis, earnings, macro data, all in one email.

AI

United States Daily Briefings

More →

Economic Calendar

More →
24/7

Crypto

More →

Investing

More →
market.newsPRO

Market Intelligence faster than Bloomberg

Real-time alerts, deeper analysis, and AI-powered desk briefings — built for serious investors.

Start Free Trial →

No credit card required

Community
Join the market.news Community
Discuss markets, earnings & macro with traders and investors worldwide
Join Free →
📈

Stay ahead of United States markets

Get the AI-powered Daily Briefing — full United States market analysis with 9 indicator panels per article. Daily — 6am ET. Free.

Join Community

No spam. Unsubscribe any time. AI-generated content — not financial advice.